
About Medall Spark Diagnostics Nashik Private Limited
Data last updated:
Medall Spark Diagnostics Nashik Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Medall Scans And Labs Private Limited. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 09 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74120TN2013PTC091043. Its GSTIN is 27AAICM5784G1Z1 (Maharashtra).
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.5 Cr. It is led by directors Balakrishnan Janardhanan and Srinathan Rajagopalan.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.34 Lakh, a decline of 98% compared to the previous year. For the same year it recorded a net profit of ₹52.63 Lakh and EBITDA of ₹22,000 (EBITDA margin 6.6%). Revenue has declined at a compounded annual rate (CAGR) of 83% over three years and 67% over five years.
The company is associated with 1 brand: Medall. The company has 1 deal on record (1 funding round), with disclosed funding of ₹4.19 Cr; the latest was in July 2013. The company has 16 MSME Form 1 returns on record between 2019 and 2022, listing 127 overdue payments to 6 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medall.in.
Company details
Contact details
Medall Spark Diagnostics Nashik Private Limited's registered office is in Chennai, Tamil Nadu. Its website is medall.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Apps
- Registered AddressNo.191, Poonamallee High Road, Chennai, Tamil Nadu, India – 600010
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Medall Spark Diagnostics Nashik Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medall Spark Diagnostics Nashik Private Limited
FY 2024 filings availableMedall Spark Diagnostics Nashik Private Limited reported revenue of ₹3.34 Lakh (down 98% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 67% over five years, including a 98% fall in the latest year. EBITDA rose 100% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹52.63 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | ||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medall Spark Diagnostics Nashik Private Limited, buy the company report.
Board of directors of Medall Spark Diagnostics Nashik Private Limited
Medall Spark Diagnostics Nashik has 2 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balakrishnan Janardhanan | Additional Director | 05 Jun 2025 | 1 Years 5 Months | Current |
| Srinathan Rajagopalan | Additional Director | 27 Sep 2025 | 1 Years 1 Months | Current |
Auditor
Medall Spark Diagnostics Nashik Private Limited is audited by ASA & Associates LLP for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASA & Associates LLP | FY 2019 | N500006 |
Shareholding
The shareholding of Medall Spark Diagnostics Nashik Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medall Spark Diagnostics Nashik Private Limited, buy the company report.
Deals & funding
Medall Spark Diagnostics Nashik Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹4.19 Cr; the latest was in July 2013.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2013 | Funding round | ₹4.19 Cr | Investors: Medall Scans and Labs Private Limited , 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Medall Spark Diagnostics Nashik Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Medall Spark Diagnostics Nashik Private Limited has 16 MSME Form 1 returns on record between 2019 and 2022, listing 127 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Harnet Printing India Pvt Ltd | |||
| Microlyn Healthcare Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| Transasia Bio-Medicals Limited |
To see the full MSME payment records of Medall Spark Diagnostics Nashik Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Medall Spark Diagnostics Nashik has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICM5784G1Z1 | Maharashtra | Active | 28 Jun 2017 |
To see the full GST registrations and return filing status of Medall Spark Diagnostics Nashik Private Limited, buy the company report.
Recent activity
Medall Spark Diagnostics Nashik Private Limited has 19 board changes on record since 2014: 4 appointments and 15 cessations. The latest: Srinathan Rajagopalan was appointed as Additional Director on 27 Sep 2025.
10 earlier events are in the company report.
News
Frequently asked questions
Medall Spark Diagnostics Nashik is an active private limited company based in Chennai, Tamil Nadu, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 09 May 2013 (13+ years old) and is registered under CIN U74120TN2013PTC091043.
Medall Spark Diagnostics Nashik has 2 current directors:
- Balakrishnan Janardhanan - Additional Director
- Srinathan Rajagopalan - Additional Director
The latest financial statements of Medall Spark Diagnostics Nashik on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Medall Spark Diagnostics Nashik is 27AAICM5784G1Z1, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medall Spark Diagnostics Nashik is U74120TN2013PTC091043. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medall Spark Diagnostics Nashik was incorporated on 09 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Chennai.
Medall Spark Diagnostics Nashik has 1 deal on record (1 funding round), with disclosed funding of ₹4.19 Cr; the latest was in July 2013.
Srinathan Rajagopalan was appointed as Additional Director on 27 Sep 2025. Sri Venugopala Rao Chittoory was appointed as Additional Director on 25 Jul 2025. Sri Venugopala Rao Chittoory ceased to be Additional Director on 06 Jun 2025. Medall Spark Diagnostics Nashik has 19 board changes on record in total.
Medall Spark Diagnostics Nashik has 16 MSME Form 1 returns on record between 2019 and 2022, listing 127 overdue payments to 6 micro and small suppliers. The latest return was filed on 30 Jun 2022.
Medall Spark Diagnostics Nashik can be reached through the website medall.in. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Medall Spark Diagnostics Nashik is at No.191, Poonamallee High Road, Chennai, Tamil Nadu, India – 600010.

